These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 18358371)

  • 1. Thromboprophylaxis and peripheral nerve blocks in patients undergoing joint arthroplasty.
    Chelly JE; Schilling D
    J Arthroplasty; 2008 Apr; 23(3):350-4. PubMed ID: 18358371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors associated with thromboprophylaxis for orthopedic patients and their impact on outcome.
    Muntz JE; O'Connor PJ; Yin H; Vogenberg FR
    Am J Orthop (Belle Mead NJ); 2007 Apr; 36(4):193-7. PubMed ID: 17515185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ACCP guidelines for thromboprophylaxis in total hip and knee arthroplasty.
    Colwell CW
    Orthopedics; 2009 Dec; 32(12 Suppl):67-73. PubMed ID: 20201479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New oral anticoagulants for thromboprophylaxis after total hip or knee arthroplasty.
    Friedman RJ
    Orthopedics; 2009 Dec; 32(12 Suppl):79-84. PubMed ID: 20201481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RE: Thromboprophylaxis and peripheral nerve blocks in patients undergoing joint arthroplasty.
    Fujiwara Y
    J Arthroplasty; 2010 Jan; 25(1):170; author reply 170-1. PubMed ID: 19729274
    [No Abstract]   [Full Text] [Related]  

  • 6. [The cost-effectiveness of fondaparinux compared to enoxaparin as prophylaxis for deep-vein thrombosis in Denmark].
    Olsen J; Gundgaard J; Borris LC
    Ugeskr Laeger; 2005 May; 167(21):2273-9. PubMed ID: 15962854
    [No Abstract]   [Full Text] [Related]  

  • 7. Ximelagatran for the prevention of venous thromboembolism following elective hip or knee replacement surgery.
    Colwell C; Mouret P
    Semin Vasc Med; 2005 Aug; 5(3):266-75. PubMed ID: 16123914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Thromboprophylaxis in hip and knee arthroplasty. Are the new anticoagulants better than those previously used?].
    Nielsen JD
    Ugeskr Laeger; 2005 May; 167(21):2261-5. PubMed ID: 15962850
    [No Abstract]   [Full Text] [Related]  

  • 9. Rationale for thromboprophylaxis in lower joint arthroplasty.
    Colwell CW
    Am J Orthop (Belle Mead NJ); 2007 Sep; 36(9 Suppl):11-3. PubMed ID: 17948162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deep vein thrombosis and pulmonary embolism in patients undergoing total hip arthroplasty: the promise of new oral anticoagulants.
    Muntz J
    J Surg Orthop Adv; 2011; 20(4):215-9. PubMed ID: 22381412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of Superficial and Deep Blocks with Rivaroxaban.
    Chelly JE; Metais B; Schilling D; Luke C; Taormina D
    Pain Med; 2015 Oct; 16(10):2024-30. PubMed ID: 26177810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thromboprophylaxis practice patterns in two Western Australian teaching hospitals.
    Eikelboom JW; Mazzarol A; Quinlan DJ; Beaver R; Williamson J; Yi Q; Hankey GJ;
    Haematologica; 2004 May; 89(5):586-93. PubMed ID: 15136222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of clinical pulmonary embolism after joint surgery in patients receiving low-molecular-weight heparin prophylaxis in hospital: a 10-year prospective register of 3,954 patients.
    Dahl OE; Gudmundsen TE; Bjørnarå BT; Solheim DM
    Acta Orthop Scand; 2003 Jun; 74(3):299-304. PubMed ID: 12899550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deep vein thrombosis prophylaxis.
    Weber KL; Zuckerman JD; Watters WC; Turkelson CM
    Chest; 2009 Dec; 136(6):1699-1700. PubMed ID: 19995776
    [No Abstract]   [Full Text] [Related]  

  • 15. Multimodal venous thromboembolic disease prevention for patients undergoing primary or revision total joint arthroplasty: the role of aspirin.
    Berend KR; Lombardi AV
    Am J Orthop (Belle Mead NJ); 2006 Jan; 35(1):24-9. PubMed ID: 16475420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of wound healing after total knee arthroplasty in a randomized prospective trial comparing fondaparinux with enoxaparin.
    Bonneux IM; Bellemans J; Fabry G
    Knee; 2006 Mar; 13(2):118-21. PubMed ID: 16387501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Efficacy and safety of aspirin in prevention of venous thromboembolism after total joint arthroplasty].
    Tian H; Song F; Zhang K; Liu Y
    Zhonghua Yi Xue Za Zhi; 2007 Dec; 87(47):3349-52. PubMed ID: 18478950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolonged enoxaparin therapy to prevent venous thromboembolism after primary hip or knee replacement. A cost-utility analysis.
    Haentjens P; De Groote K; Annemans L
    Arch Orthop Trauma Surg; 2004 Oct; 124(8):507-17. PubMed ID: 15365714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for pulmonary embolism and the effects of fondaparinux after total hip and knee arthroplasty: a retrospective observational study with use of a national database in Japan.
    Nagase Y; Yasunaga H; Horiguchi H; Hashimoto H; Shoda N; Kadono Y; Matsuda S; Nakamura K; Tanaka S
    J Bone Joint Surg Am; 2011 Dec; 93(24):e146. PubMed ID: 22258781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of ACCP and AAOS guidelines for VTE prophylaxis after total hip and total knee arthroplasty.
    Lachiewicz PF
    Orthopedics; 2009 Dec; 32(12 Suppl):74-8. PubMed ID: 20201480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.